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INTRODUCTION 
Drug utilization evaluation is a tool to evaluate 
appropriateness of drug therapy. The intention is to 
recognize whether current patterns of prescribing, 
dispensing and use of drug therapy are reliable with 
criteria and standards. These criteria and standards are 
to demonstrate the drug therapy is effective, safe, 
appropriate, and cost effective and support optimal 
patient outcome .
1
 Urinary Tract Infection (UTI) is one 
of the most common clinical syndromes encountered in 
general and gynaecological practices.
2 
Most often, UTI 
is caused by a bacterial infection and can cause serious 
complications, if left untreated. Today, UTI represents 
one of the most common diseases with an estimated 
worldwide incidence of 150 million per annum. 
Although UTIs occur in both men and women, clinical 
studies suggest that its overall prevalence is higher in 
women. UTI is also a common problem during 
pregnancy, particularly beginning at week 6 and 
peaking during weeks 22 to 24.
3
 Several studies 
reported that untreated bacteriuria in pregnancy either 
asymptomatic or symptomatic is associated with 50% 
increase in the risk of stillbirth and a significant increase 
in the risk of pre-eclampsia, hypertension, anemia, and 
postpartum endometritis.
4-7
 Studies also report that  
diabetes mellitus is a well recognized risk factor for the 
occurrence of UTI. UTI is a common illness in children, 
with overall prevalence ranging from 2-8% throughout 
childhood as reported in the studies.
8-10
 
UTI treatment depends on location (cystitis vs. 
pyelonephritis), patient’s age, severity of presentation, 
and the antimicrobial resistance pattern in the 
community. Empiric therapy for UTI should be initiated 
after urine culture sensitivity test of urine specimen has 
been obtained. The antibiotic choice should be based on 
pathogen identification, sensitivity from urine culture 
and comorbid diseases related to the patient. 
Therapy to uncomplicated UTI usually begins before 
the results of microbiological tests are known. The 
rationale for this approach is based on the highly 
predictable spectrum of etiological agents causing UTI 
and their antimicrobial resistance pattern in the given 
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population. Recurrent urinary tract infection (RUTI) is 
explained as three episodes of UTI in the last twelve 
months or two episodes in the last six months. Some 
studies estimate that 20-30 % of woman who has a UTI 
would have an RUTI. A different approach has been 
proposed for the prevention of RUTI and include non 
pharmacological therapies such as avoiding sexual 
intercourse and ingestion of cranberry juice. 
To improve the patient compliance, it is mandatory to 
continue drug utilization study and adverse drug 
reactions (ADRs) monitoring.  Thus, the aim of this 
study is to improve patient care, risk assessment and 
cost benefits in relation to the use of medicines. This 
also promotes the understanding, education and clinical 
training in pharmacovigilance and its effective 
communication to health professionals and the public. 
MATERIALS AND METHODS 
This study was a four month prospective observational 
drug utilization study focusing on the prescribing 
patterns, sensitivity to antibiotics and the ADRs with the 
antibiotics prescribed for UTI patients of all age groups 
were included in the study. Mid stream urine were 
collected in sterile urine culture bottle to specify 
antibiotic sensitivity. A total of 327 females were 
interviewed. All the observations were recorded in the 
drug utilization form and ADR monitoring form. A 
Patient profile (age, weight, height, patient address, 
socio economic status, educational status, marital status, 
pregnancy), susceptibility factors for UTI, past history 
of UTI, concomitant conditions, if undergone any 
urogenital surgery, eating habits, urine culture and 
sensitivity report of the pathogen were recorded. 
Pregnant patients were separately interviewed and 
recorded for the diseased condition and concomitant 
drug use. Drugs prescribed for UTI to patients, drug 
dose and frequency, adverse drug reaction, ifany, due to 
the antibiotics prescribed were also noted. Individuals 
who did not give verbal informed consent or had 
complicated infection were not included in the study. 
OBSERVATIONS AND RESULTS 
During the period of four months (January 2013 to April 
2013) of the study, a total of 327 patients with UTI were 
evaluated in the HAH Centenary Hospital, Jamia 
Hamdard. Age distribution reflects maximum of 165 
(50.46%) in the age group 21-30 years, followed by 61 
(18.65%) in the age group of 31-40 years [Table 1].
 
 
Table 1: Age wise distribution of patients 
 
 
 
 
 
 
 
 
 
 
Out of 327 patients suffering from UTI, 248 (75.84%) 
cases were symptomatic while 79 (24.16%) cases were 
asymptomatic [Figure 1]. Isolated pathogens in urine 
were of both Gram positive 131 (40.07%) and Gram 
negative 196 (59.93%) type.Most common Gram 
positive pathogens causing UTI was found to be 
Staphylococcus aureus as urine culture of 91 (27.83%)  
patients were positive for this bacteria followed by 25 
(7.63%) patients positive for Enterococcus faecalis and 
10 (4.28%) patients positive for Streptococcus 
pyogenes. Incidence of Methicillin resistant S. aureus 
was least, only one case detected positive for this 
bacterium. Among gram negative bacteria, Escherichia 
coli 118 (36.09%) were the most common, followed by 
Pseudomonas aeruginosa 18 (5.50%) and Klebsiella 
pneumonia 16 (3.28%). [Table 2] 
 
Figure 1: Classification of UTI
 
 
S. No. Age group(yrs) No. of patients Percentage (%) 
1 1-10 8 2.44 
2 11-20 24 7.34 
3 21-30 165 50.46 
4 31-40 61 18.65 
5 41-50 33 10.09 
6 51-60 18 5.50 
7 61-70 11 3.36 
8 Above 70 7 2.14 
 Total 327 100 
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Table 2: Frequency of isolation of various pathogens detected in urine 
 
Pathogens 
Number and percentage of pathogens in 
P (%) NP (%) Total (%) 
Gram +ve Staphylococcus aureus 29 8.87 62 18.96 91 27.83 
 Enterococcus  faecalis 10 3.06 15 4.59 25 7.65 
 Streptococcus pyogenes 10 3.06 4 1.22 14 4.28 
 Methicillin resistant  S. aureus 0 0.00 1 0.31 1 0.31 
Gram –ve Escherichia coli 51 15.60 67 20.49 118 36.09 
 Klebsiellaoxytaca 2 0.61 10 3.06 12 3.67 
 Klebsiella pneumonia 5 1.53 9 2.75 12 4.28 
 Proteus mirabilis 2 0.61 1 0.31 3 0.92 
 Pseudomonas aeruginosa 7 2.14 11 3.36 18 5.50 
 Morganellamorganii 5 1.53 1 0.31 6 1.84 
 Salmonella typhi 1 0.31 0 0.00 1 0.31 
 Enterobacterfaecalis 0 0.00 3 0.92 3 0.92 
 Acinetobacterbaumannii 4 1.22 6 1.83 10 3.05 
 Provindenciarettgeri 5 1.53 6 1.83 11 3.36 
Total  131 40.06 196 59.94 327 100 
 
It has been observed that UTI was most common during 26-40 weeks of pregnancy as out of 131 pregnant cases, 
60(45.80%) patients came to treatment in the HAHC hospital during the above gestational age [Table 4]. 
 
Table 3: Demographic characteristics of UTI patients 
(a)Marital status 
Marital Status Number of cases Percentage (%) 
Married 260 79.51 
Unmarried 67 20.49 
Total 327 100 
 
(b)Social status  
Social  Status Number of cases Percentage (%) 
High( MI above 20k) 16 4.89 
Middle ( MI between 10-20k) 54 16.51 
Low( MI below 10k) 257 78.60 
Total 327 100 
 
(c)Educational status 
E. Status Number of cases Percentage (%) 
Illiterate 202 61.77 
Educated 80 24.46 
Highly educated 45 13.76 
Total 327 100 
 
Table 4: Prevalence of UTI in pregnant women in relation to gestational age 
Gestational Age (weeks) Number of cases Percentage (%) 
1-12 32 24.42 
13-25 39 29.80 
26-40 60 45.80 
 131 100 
 
In our study 131 cases were pregnant while 196 were 
non-pregnant. From USG (LA) of pregnant cases, 
56(42.74%) patients were diagnosed as nephritis and 
pyelonephritis. Findings of our study suggest quite 
higher percentage of nephritis in India in comparison to 
US; it may be due to poor hygienic conditions and 
humid weather of India. Susceptibility of urinary tract 
infection showed past history of biological factors like 
UTI in 18 cases (P5 and 13NP), diabetes mellitus 28(P9 
and NP 19), urinary obstruction 16 (P6 and NP10), 
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incontinence in 16(P7 and NP9). Out of 9 pregnant 
cases, gestational diabetes was reported in 7 cases. 
Menopause was also recorded in 32 cases; it may be due 
to less mucus in vaginal area with low estrogen level 
increasing the chances of infection. Behavioral factors 
like use of condom 54(P22 and NP32) and contraceptive 
pills 64(P23 and NP41) were also recorded. Besides 
these, other susceptibility factors like catheterization 
124(P72 and NP52), urogenital surgery 57(P24 NP33) 
and spinal cord injury 2(NP) were recorded [Figure2]. 
In a study done by Turan et.al in 2008, it was found that 
women taking insulin and those with longer diabetes 
duration (more than 10 yrs) are at increased risk of UTI. 
 
 
Fig. 2 Factors increasing susceptibility to UTI 
 
Antimicrobial susceptibility pattern of both gram positive 
and gram negative microorganisms was tested with 
Amoxicillin Clavulanic acid(AMC), Nitrofurantoin 
(NIT), Ofloxacin(OF), Amikacin (AK), 
Ceftrioxone(CTX), Chloramphenicol (C), Azithromycin 
(AZT), Doxycycline(DOX), Gentamycin(GEN) and 
Cefixime(CEF).The pattern of prescription reflects that 
the maximum prescribed antibiotic was the combination 
of Amoxicillin- clavulanic acid 142(43.33%) followed by 
Nitrofurantion 127(38.83%).The pattern also depicts that 
amoxicillin-clavulanic acid was mostly included in the 
prescription of non pregnant UTI cases 136(41.50%) 
while nitrofurantion in pregnant UTI cases 
120(36.69%).[Table 5, Table 6] 
Antibiotics were usually given empirically before the 
laboratory results of urine culture are available.The 
antibiotics prescribed by the doctors included 
Amoxicillin + clavulanic acid[1.2gm i.v/10-12 hrly 
375mg bid (5 days), Nitrofurantoin [50-100mg qid (4-7 
days)], Amikacin [250mg bid i.v(4-7 days)], 
Azithromycin[500mg o.d (3 days)], Cefixime[200-400mg 
o.d (4-7 days)], Ceftriaxone[250mg o.d (5 days); 1-2g 
i.v], Ofloxacin[400mg o.d (5 days)], Ciprofloxacin[250-
500mg o.d (4-7 days)], Norfloxacin[400mg bid (5 days)] 
and Doxycycline[100mg bid (7 days)].Majority of Gram 
positives were resistant to most of the antibiotics tested 
than the Gram negatives. As indicated in the Tables 33 
and 34 most of the gram positives were found sensitive to 
NIT, C and GEN and gram negatives were found 
sensitive to AK, NIT, C, GEN and AMC.Gram positives 
were found resistant to AK, CTX and DOX whereas 
Gram negatives were resistant to DOX, CEF, CTX and 
OF. [Table 5,6] 
The pattern of prescription reflects that the maximum 
prescribed antibiotic was the combination of Amoxicillin- 
clavulanic acid 142(43.33%) followed by Nitrofurantion 
127(38.83%).The pattern also depicts that amoxicillin-
clavulanic acid was mostly included in the prescription of 
non pregnant UTI cases 136(41.50%) while 
nitrofurantion in pregnant UTI cases 120(36.69%) [Table 
7]. 
Most of the antibiotics were prescribed in second and 
third trimester which possess less threat to both, mother 
and fetus as the drug prescribed in the first trimester 
(organ development phase) may lead to fetal 
abnormalities. 
ADRs are common with UTI treatment. In general, the 
common side effects are mild to moderate and self 
limiting however, occasional serious adverse effects can 
occur. Out of 142 patients prescribed with Amoxicillin 
with  Clavulanic acid, there were 13 reports of nausea 
and 2 reports of skin rash.127 patients, mostly the 
pregnants, were given Nitrofurantoin, out of which 3 
patients complained of vaginal irritation and 2 pregnant 
females reported nausea.  
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Table 5: Antimicrobial susceptibility pattern of gram positive bacteria isolated from urine culture of pregnant and non pregnant women 
 
 
 
 
 
 
 
 
 
Bacterial Isolate Total 
No. 
Pattern                                                                     Anti-microbial agents tested 
   AMC NIT OF AK CTX C AZT DOX GEN CEF 
No.(%) No.(%) No.(%) No.(%) No.(%) No.(%) No.(%) No.(%) No.(%) No.(%) 
Staphylococcus 
aureus 
91 S 25 
(27.47) 
57 
(62.63) 
20 
(21.97) 
3 
(3.29) 
27 
(29.69) 
57 
(62.63) 
1 
(1.09) 
0 
(0.00) 
40 
(43.95) 
3 
(3.29) 
R 66 
(72.52) 
34 
(37.36) 
71 
(78.02) 
88 
(96.70) 
64 
(70.32) 
34 
(37.36) 
90 
(98.90) 
91 
(100.00) 
51 
(56.04) 
88 
(96.70) 
Enterococcus  
faecalis 
25 S 5 
(20.00) 
17 
(68.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
1 
(4.00) 
0 
(0.00) 
1 
(4.00) 
2 
(8.00) 
3 
(12.00) 
R 20 
(80.00) 
8 
(32.00) 
25 
(100.0) 
25 
(100.0) 
25 
(100.0) 
24 
(96.00) 
25 
(100.00) 
24 
(96.00) 
23 
(92.00) 
22 
(88.00) 
Streptococcus 
pyogenes 
14 S 3 
(21.42) 
11 
(78.57) 
0 
(0.00) 
0 
(0.00) 
3 
(21.42) 
2 
(14.28) 
1 
(7.14) 
0 
(0.00) 
3 
(21.42) 
7 
(50.00) 
R 11 
(78.57) 
3 
(21.42) 
14 
(100.0) 
14 
(100.0) 
11 
(78.57) 
12 
(85.71) 
13 
92.85) 
14 
(100.00) 
11 
(78.57) 
7 
(50.00) 
Methicillin resistant 
S. Aureus 
1 S 0 
(0.00) 
0 
(0.00) 
1 
(100.0) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
0 
(0.00) 
1 
(100.00) 
R 1 
(100.0) 
1 
(100.00) 
0 
(0.00) 
1 
(100.0) 
1 
(100.0) 
1 
(100.0) 
1 
(100.00) 
1 
(100.00) 
1 
(100.00) 
0 
(0.00) 
 TOTAL 131 S 33 
(25.19) 
85 
(64.88) 
21 
(16.03) 
3 
(2.29) 
30 
(22.90) 
60 
(45.80) 
2 
(1.52) 
1 
(0.76) 
45 
(34.35) 
14 
(10.68) 
 R 98 
(74.80) 
46 
(35.11) 
110 
(83.96) 
128 
(97.70) 
101 
(77.09) 
71 
(54.20) 
129 
(98.48) 
130 
(99.23) 
85 
(64.88) 
117 
(89.31) 
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Table 6: Antimicrobial susceptibility pattern of gram negative bacteria isolated from urine culture of pregnant and non pregnant women 
 
 
Bacterial Isolate Total 
number 
Pattern                                                               Anti-microbial agents tested 
   AMC NIT OF AK CTX C AZT DOX GEN CEF 
No.(%) No.(%) No.(%) No.(%) No.(%) No.(%) No.(%) No.(%) No.(%) No.(%) 
Escherichia coli 118 S 52 (44.06) 79 
(66.94) 
14 
( 11.86) 
80 
(67.69) 
14 
(11.86) 
70 
(59.32) 
39 
(33.05) 
2 
(1.69) 
49 
(41.52) 
2 
(1.69) 
R 66 (55.93) 39 (33.05) 104(88.13) 38 (32.20) 104(88.1) 48 (40.67) 79 (66.94) 116(98.30) 69 (58.47) 116(98.30) 
Klebsiellaoxytaca 
 
12 
 
S 1 (8.33) 6 (50.00) 1 (8.33) 9 (75.00) 3 (25.00) 9 (75.00) 3 (25.00) 2 (16.66) 3 (25.00) 0 (0.00) 
R 11 (91.66) 5 (41.66) 11 (91.66) 3 (25.00) 9 (75.00) 3 (25.00) 9 (75.00) 10 (83.33) 9 (75.00) 12(100.00) 
Klebsiella pneumonia 
 
14 
 
S 1 (7.14) 2 (14.28 1 (7.14) 9 (64.28) 5 (35.71) 7 (50.00) 13 (92.85) 0 (0.00) 6 (42.85) 0 (0.00) 
R 13 (92.85) 12 (85.71) 13 (92.85) 5 (35.71) 9 (64.28) 7 (50.00) 1 (7.14) 14(100.00) 8 (57.14) 14(100.00) 
Proteus mirabilis 3 S 1 
(33.33) 
0 
(0.00) 
0 
(0.00) 
2 
(66.66) 
1 
(33.33) 
1 
(33.33) 
2 
(66.66) 
0 
(0.00) 
2 
(66.66) 
0 
(0.00) 
R 2 
(66.66) 
3 
(100.00) 
3 
(100.00) 
1 
(33.33) 
2 
(66.66) 
2 
(66.66) 
1 
(33.33) 
3 
(100.00) 
1 
(33.33) 
3 
(100.00) 
Pseudomonas 
aeruginosa 
18 S 1 
(5.55) 
1 
(5.55) 
3 
(16.66) 
15 
(83.33) 
1 
(5.55) 
5 
(27.77) 
8 
(44.44) 
0 
(0.00) 
11 
(61.11) 
1 
(5.55) 
R 17 
(94.44) 
17 
(94.44) 
15 
(83.33) 
3 
(16.66) 
17 
(94.44) 
13 
(72.22) 
10 
(55.55) 
18 
(100.00) 
7 
38.88) 
17 
(94.44) 
Morganellamorganii 6 S 0 
(0.00) 
3 
(50.00) 
1 
(16.66) 
5 
(83.33) 
4 
(66.66) 
3 
(50.00) 
4 
(66.66) 
0 
(0.00) 
1 
(16.66) 
1 
(16.66) 
R 6 
(100.00) 
3 
(50.00) 
5 
(83.33) 
1 
(16.66) 
2 
(33.33) 
3 
(50.00) 
2 
(33.33) 
6 
(100.00) 
5 
(83.33) 
5 
(83.33) 
Enterobacterfaecalis 3 S 0 
(0.00) 
3 
(100.00) 
1 
(33.33) 
3 
(100.00) 
1 
(33.33) 
1 
(33.33) 
0 
(0.00) 
0 
(0.00) 
1 
(33.33) 
0 
(0.00) 
R 3 
(100.00) 
0 
(0.00) 
2 
(66.66) 
0 
(0.00) 
2 
(66.66) 
2 
(66.66) 
3 
(100.00) 
3 
(100.00) 
2 
(66.66) 
3 
(100.00) 
Acinetobacterbaumann
ii 
10 S 0 
(0.00) 
4 
(40.00) 
2 
(20.00) 
7 
(70.00) 
5 
(50.00) 
4 
(40.00) 
2 
(20.00) 
0 
(0.00) 
7 
(70.00) 
0 
(0.00) 
R 10 
(100.00) 
6 
(60.00) 
8 
(80.00) 
3 
(30.00) 
5 
(50.00) 
6 
(60.00) 
8 
(80.00) 
10 
(100.00) 
3 
(30.00) 
10 
(100.00) 
Provindenciarettgeri 11 S 4 
(36.36) 
9 
(81.81) 
3 
(27.27) 
10 
(90.90) 
4 
(36.36) 
7 
(63.63) 
4 
(36.36) 
0 
(0.00) 
1 
(9.09) 
1 
(9.09) 
R 7 
(63.63) 
2 
(18.18) 
8 
(72.72) 
1 
9.09) 
7 
(63.63) 
4 
(36.36) 
7 
(63.63) 
11 
(100.00) 
10 
(90.90) 
10 
(90.90) 
Total 195 S 60 
(30.61) 
107 
(54.59) 
26 
(13.26) 
141 
(71.94) 
39 
(19.90) 
107 
(54.59) 
76 
(38.78) 
4 
(2.04) 
81 
(41.32) 
5 
(2.55) 
 R 136 
(69.38) 
88 
(44.90) 
163 
(86.73) 
54 
(27.55) 
158 
(80.61) 
89 
(45.40) 
120 
(61.22) 
192 
(97.95) 
110 
(56.12) 
191 
(97.44) 
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Table 7: Drugs prescribed for UTI 
 
Table 8: Adverse drug reactions encountered by the use of antibiotics 
S.No. Antibiotic ADR  No. of Cases 
1 Amoxicillin + clavulanic  acid Nausea 
Skin Rashes 
13                                                  
2 
2 Nitrofurantoin Vaginal irritation 
Nausea 
3                                                 
9 
3 Amikacin Headache 
Nausea & Vomiting 
1                                               
2 
4 Azithromycin Abdominal pain 
Nausea 
3                                               
2 
5 Cefixime Nausea 2 
6 Ceftriaxone Watery stool 1 
7 Ofloxacin Metallic taste 
Nausea 
3                                                       
2 
 Ciprofloxacin Metallic taste 
Nausea & vomiting 
Photosensitivity 
7                                                           
3                                                              
1                                                                 
9 Norfloxacin Metallic taste 
Nausea & vomiting 
4                                                        
2 
10 Doxycycline Diarrhoea 1 
   61 
 
Record of socioeconomic status [Table 3] of the patients depicts that the chances of 
UTI are quite high in patients of low socioeconomic status 257(78.59%) which proves 
that the living conditions and hygiene is poor in low socioeconomic status as 
compared to high socioeconomic status. Similarly the incidence of UTI was higher in 
illiterate 202(61.77%) that reflects that the education increases the sense of hygiene 
and therefore decreases the chances of infection. 
DISCUSSION 
In developing countries it is important to conduct drug utilization studies to rationalize 
the drug use in clinical practice. Keeping in mind, we proposed this work to measure 
the prescribing pattern of different cases of UTI in HAHC Hospital which is a 350 
bedded teaching hospital of Jamia Hamdard University, New Delhi (India). The study 
focused on pregnant as well as non pregnant patients taking treatment in OPD as well 
as IPD. During the 4 months period of our study, a total of 327 patients suffering from 
different types of UTI attending HAH Centenary Hospital were evaluated.  
As previously reported the UTI is common during 26-40 weeks of pregnancy. The 
maximum incidence of UTI during last trimester may be due to anatomical changes in 
the genital organs occurring due to the pressure exerted by the foetus on the walls of 
urinary bladder and ureters causes to urine remains stagnate that further leads to the 
bacterial growth. 
Our analysis reflects the increased number of symptomatic cases having fever, pain in 
micturition and hematurea in comparison to asymptomatic cases.
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Class of Antibiotic Antibiotic  Dosage                                 Prescribed to treat UTI  in  
Pregnant (%) Trimester Non Pregnant (%) Total (%) 
PENICILLIN Amoxicillin + 
clavulanic  acid 
1.2gm i.v/10-12 hrly 
375mg bid (5days) 
 6 (1.83) 1,2 136(41.50) 142(43.33) 
NITROFURAN Nitrofurantoin 50-100mg qid (4-7 days) 120 (36.69) 1,2,3 7 (2.14) 127(38.83) 
AMINOGLYCOSIDE Amikacin 250mg bid i.v (4-7 days) 0 (0) - 10 (3.05) 10(3.05) 
MACROLIDE Azithromycin 500mg o.d (3days) 3 (0.91) 2,3 13 (3.98) 16(4.89) 
CEPHALOSPORIN Cefixime 200-400mg o.d (4-7 days) 1(0.30) 2 7 (2.14) 8(2.44) 
CEPHALOSPORIN Ceftrioxone 250mg o.d (5 days); 1-2g i.v 0(0) - 2 (0.61) 2(0.61) 
FLOROQUINOLONE Ofloxacin 400mg o.d (5 days) 0(0) - 5 (1.52) 5(1.52) 
FLOROQUINOLONE Ciprofloxacin 250-500mg o.d (4-7 days) 1(0.30) 3 2 (0.61) 3(0.91) 
FLOROQUINOLONE Norfloxacin 400mg bid (5 days) 0(0) - 8 (2.45) 8(2.45) 
TETRACYCLINE Doxycycline 100mg bid (7 days) 0(0) - 6 (3.36) 6(3.36) 
Total   131  196  327(100) 
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The isolated pathogens in urine culture were of both from positive and gram negative type 
as also reported earlier.
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Susceptibility to UTI infection showed past history of biologic 
factors like UTI, diabetes mellitus, urinary obstruction, incontinence. Antimicrobial 
susceptibility pattern also depicted that amoxicillin with clavulanic acid was mosly 
included in the prescription of non pregnant UTI cases, while nitrofurantoin was the drug 
of choice in the pregnant UTI cases.  
Most of the antibiotics were prescribed in second and third trimester, which possess less 
threat to both, mother and foetus as the drug prescribed in the first trimester (organogenesis 
phase) may lead to foetal abnormalities.  
Six recurrent cases were recorded after the first episode of UTI within 2-6 weeks of 
treatment. The reoccurance was due to diabetes, menopause, contraceotiveuse and 
catheterization, etc.
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Multi drug resistance (if, resistance in ≥ 2 drugs) was seen in most of the isolated bacterial 
uropathogens. This indicates that multi drug resistance was found to be very high to the 
commonly used antibiotics. Therefore, the reasons for this alarming phenomenon might be 
inappropriate and incorrect administration of antimicrobial agents in empirical therapies 
and lack of appropriate infection control strategies, which can cause a shift to increase 
prevalence of resistant organism in the community. 
ADRs are common with UTI treatment. In general, the common side effects are mild to 
moderate and self limiting. However, occasional side effects occurred specially nausea and 
skin rashes with use of Amoxycillin with Clavulanic acid.  
Previous data on socioeconomic status of the patients depicts that the chances of UTI in 
patients that have unhygienic condition. Consistently, the incidence of UTI was higher in 
illiterate cases that reflect that the condition increases the sense of hygiene and therefore 
decreases the chances of infection.  
Excessive use of spicy food, alcohol, cigarette smoking, pan masala, tea, coffee, soft 
drinks, may be predisposing factors for UTI.  Those who take fluids in excess quantity are 
less liable to have a UTI. 
CONCLUSION 
UTI is the most common bacterial infection. It is generally associated with minimal 
morbidity except among specific subpopulations. However, there is a significant absence of 
data regarding its accurate incidence, factors that increase susceptibility to UTI, and the 
long-term medical sequelae of UTI. It is the prevalent complication of pregnancy that can 
worsen maternal and prenatal prognosis. Untreated asymptomatic forms can progress to 
pyelonephritis, which is associated with preterm delivery, low birth weight infants and 
stillbirth. We studied the drug utilization pattern of patients of UTI visiting HAHC 
Hospital, New Delhi. 
The study strongly recommends the need of patient education and counselling for 
managing UTI which has been always undermined due to which the burden of UTI is 
increasing exponentially. Antibiotics are given empirically before the laboratory results of 
urine culture are available. To ensure appropriate therapy, current knowledge of the 
organism that causes UTIs and their antibiotic susceptibility pattern is mandatory. In 
addition to the increased incidence of UTI during gestation, health care professionals 
should be aware that the choice of available anti-infective drugs are restricted, given the 
risk of certain of them for the fetus, and the potential for bacterial resistance. 
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